These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 3916502

  • 1. Improved immunosuppression for heart transplantation.
    Bolman RM, Elick B, Olivari MT, Ring WS, Arentzen CE.
    J Heart Transplant; 1985 May; 4(3):315-8. PubMed ID: 3916502
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.
    Casale AS, Reitz BA, Greene PS, Augustine S, Baumgartner WA.
    J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):951-5. PubMed ID: 2811426
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reduction of infectious complications following heart transplantation with triple-drug immunotherapy.
    Andreone PA, Olivari MT, Elick B, Arentzen CE, Sibley RK, Bolman RM, Simmons RL, Ring WS.
    J Heart Transplant; 1986 Nov; 5(1):13-9. PubMed ID: 3302153
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy.
    Imakita M, Tazelaar HD, Billingham ME.
    J Heart Transplant; 1986 Nov; 5(4):279-85. PubMed ID: 3305819
    [Abstract] [Full Text] [Related]

  • 8. Arterial hypertension in heart transplant recipients treated with triple-drug immunosuppressive therapy.
    Olivari MT, Antolick A, Ring WS.
    J Heart Transplant; 1989 Nov; 8(1):34-9. PubMed ID: 2647929
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients.
    Paraiso AR, Ona ET, Alano FA, Ramos CP, De Luna M.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530
    [No Abstract] [Full Text] [Related]

  • 12. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
    Posner MP, Mendez-Picon G, King A, Nelson KP, Spicer HG, Lee HM.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Management of cyclosporine toxicity by reduced dosage and azathioprine.
    Griffith BP, Hardesty RL, Lee A, Trento A, Thompson ME, Shapiro AP, Bahnson HT.
    J Heart Transplant; 1985 Feb; 4(4):410-3. PubMed ID: 3916516
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Self-reported change in physical symptoms from cyclosporine-based therapy to azathioprine-based therapy in heart transplant recipients.
    Lough ME, Miller JL, Gamberg P.
    J Heart Transplant; 1986 Feb; 5(4):322-6. PubMed ID: 3305825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.